New Risk • 10h
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CA$5.1m). Market cap is less than US$10m (US$809.0k market cap). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (19% increase in shares outstanding). Announcement • Jul 28
IM Cannabis Corp. Announces Resignation of Alon Dayan as Director, Effective July 26, 2026 IM Cannabis Corp. announced that on July 26, 2026, Mr. Alon Dayan notified the board of directors of IM Cannabis Corp. (the Company") of his resignation from his position as a member of the board of directors for personal reasons, effective July 26, 2026. Announcement • Jul 02
IM Cannabis Corp. announced that it has received $0.2025 million in funding from L.I.A. Pure Capital Ltd. IM Cannabis Corp entered into a Note Purchase Agreement with L.I.A. Pure Capital Ltd. and closed the transaction by issuing convertible promissory note in the principal amount of $225,000 at 10% original issuance discount for the proceeds of $202,500 along with a warrant to purchase up to 1,483,386 Common Shares on July 1, 2026. The Note bears an interest rate of eight percent (8.0%) per annum and conversion price is $0.152. The Warrant became exercisable immediately upon its issuance date, July 1, 2026, and will be exercisable for a period of five (5) years, until July 1, 2031 and exercise price is $0.15(CAD 0.22). This Note shall have no maturity date. 
